Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial
about
Epidemiology and Inherited Predisposition for Sporadic Pancreatic AdenocarcinomaAssociation between diabetes or antidiabetic therapy and lung cancer: A meta-analysisSerum Insulin-Like Growth Factor Axis and the Risk of Pancreatic Cancer: Systematic Review and Meta-Analysis.Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I data.Protein secretion is required for pregnancy-associated plasma protein-A to promote lung cancer growth in vivo.Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms.TM4SF4 overexpression in radiation-resistant lung carcinoma cells activates IGF1R via elevation of IGF1.Application of proteomics to cancer early detectionPrediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study.Effect of patient navigation on colorectal cancer screening in a community-based randomized controlled trial of urban African American adults.Targeting the insulin-like growth factor receptor pathway in lung cancer: problems and pitfalls.Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition.Circulating Leptin and Risk of Pancreatic Cancer: A Pooled Analysis From 3 Cohorts.Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma PathophysiologyPrognostic implications of tumoral expression of insulin like growth factors 1 and 2 in patients with non-small-cell lung cancer.Insulin caused drug resistance to oxaliplatin in colon cancer cell line HT29.Maternal BMI, IGF-I Levels, and Birth Weight in African American and White InfantsExpression of insulin-like growth factor family genes in clear cell renal cell carcinoma.Associations of insulin-like growth factor and insulin-like growth factor binding protein-3 with mortality in women with breast cancerPancreatic cancer biomarkers and their implication in cancer diagnosis and epidemiology.Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma.AKT-induced PKM2 phosphorylation signals for IGF-1-stimulated cancer cell growth.Biology and significance of signalling pathways activated by IGF-II.Height and pancreatic cancer risk: a systematic review and meta-analysis of cohort studies.Obesity Biomarkers, Metabolism and Risk of Cancer: An Epidemiological Perspective.Obesity-associated digestive cancers: A review of mechanisms and interventions.Prediagnosis Circulating Insulin-Like Growth Factors and Pancreatic Cancer Survival.Role of Insulin-like Growth Factor, Insulin-like Growth Factor Receptors, and Insulin-like Growth Factor-binding Proteins in Ovarian Cancer.Glycemic index, glycemic load and cancer risk.Cross-sectional and longitudinal associations between insulin-like growth factor I and metabolic syndrome: a general population study in German adults.Association between the insulin-like growth factor axis in serum and periodontitis in the Study of Health in Pomerania: an exploratory study.Insulin/IGF-driven cancer cell-stroma crosstalk as a novel therapeutic target in pancreatic cancer.Inflammatory, insulin resistance metabolic markers and pancreatic cancer: quo vadis? [corrected].Robust Nonnegative Matrix Factorization via Joint Graph Laplacian and Discriminative Information for Identifying Differentially Expressed Genes
P2860
Q26801418-C0FB26F9-9CFD-423F-8BF5-6AED74C4FE37Q33607800-60E34896-FDB6-4E47-9584-05B8BCA87150Q33616917-B799854D-C537-4AB0-9AB9-F88EBF2A1F6AQ33857217-792D75E5-76EB-4587-9006-7688B1FD13B8Q34477488-17DCDB5A-D430-4DC1-9E36-D6708C5EB70AQ34634257-83AA0B57-3C53-4DB8-9F3A-7A039F366E56Q34654685-EEF6237F-16C3-45BB-BB1D-7663FAB6AA78Q35053031-8678737B-112B-42AA-BF6A-BD6C30E54B72Q35152701-B9D76155-BF6D-40E6-9BE9-A2B75B3CE4F4Q35207512-23002D88-B860-40E6-BF28-6F649E93A7E1Q35810171-6669DCA2-4AF3-425F-8425-AD142F02A70BQ35835118-34D99976-8EEA-4B3B-B821-0E00613A5590Q35896957-7660DFD7-E643-4D13-8054-9B0B1186A9E4Q35903573-B4E2C9B2-7E4B-4EB1-9088-B85DD9FD7295Q36066604-6E2BE45E-38F3-4E74-9984-7162F26D2BEDQ36097117-66DD16F6-94C3-46ED-811D-AF2D2CD7F862Q36938944-953D3BE8-03E1-4303-A9E5-AAF7BD25C2E6Q37048923-100AC279-9588-4E96-A82A-EA2C81E4D44FQ37151431-8897AC73-F1F5-4028-B21E-AEA7E784D576Q37342746-E4F16843-8EA6-4A6B-8534-259CE523E17AQ37520401-BDF0C26B-FBFB-4AA3-82E5-12336B89FAABQ37565415-885A1390-F9B3-4E7A-841F-AF9EEB8DF89DQ37963987-0B1DDF3D-FA22-4337-BCEC-48C4BC4713EAQ38017977-20148E25-6942-43BF-879C-1E669C398ABCQ39026672-C9098D6C-4368-4C70-B10D-866B9B6AAD2EQ39205170-38A8AE2C-6C7C-483A-BECF-5A31583FFC59Q40133659-C6F25E36-D989-4BBD-BE6C-75FA25673A92Q41601838-DFA4144B-D798-47B6-8129-07B17CF459DFQ43657929-87521337-AA49-4636-99FE-E64B2B34FFA3Q44911949-8B973B49-938D-4E44-BD40-D195434AD5B8Q46857844-A570FF6B-3DAF-49C5-BE81-3F78243D8416Q50314975-3B57AD9B-E467-433F-91A7-53AFDE684DC2Q51217477-A194A718-018D-4BB6-8FED-EEB9AD0D9432Q59142901-F3FE4783-C2FE-43EF-86FD-F9B1B06C54F6
P2860
Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Serum IGF-I, IGF-II, IGFBP-3, ...... ovarian cancer screening trial
@ast
Serum IGF-I, IGF-II, IGFBP-3, ...... ovarian cancer screening trial
@en
Serum IGF-I, IGF-II, IGFBP-3, ...... ovarian cancer screening trial
@nl
type
label
Serum IGF-I, IGF-II, IGFBP-3, ...... ovarian cancer screening trial
@ast
Serum IGF-I, IGF-II, IGFBP-3, ...... ovarian cancer screening trial
@en
Serum IGF-I, IGF-II, IGFBP-3, ...... ovarian cancer screening trial
@nl
prefLabel
Serum IGF-I, IGF-II, IGFBP-3, ...... ovarian cancer screening trial
@ast
Serum IGF-I, IGF-II, IGFBP-3, ...... ovarian cancer screening trial
@en
Serum IGF-I, IGF-II, IGFBP-3, ...... ovarian cancer screening trial
@nl
P2093
P2860
P1476
Serum IGF-I, IGF-II, IGFBP-3, ...... ovarian cancer screening trial
@en
P2093
Amr S Soliman
Debra T Silverman
Jason B Douglas
Michael N Pollak
Yuzhen Tao
P2860
P304
P356
10.1158/1055-9965.EPI-10-0400
P577
2010-08-10T00:00:00Z